Harkness Pharmaceuticals Company Disease Technology Human Trials Contact References
Harkness Pharmaceuticals
CLINICAL TRIALS

Harkness Pharmaceuticals is currently undertaking a detailed clinical investigation of the effects of oral dosing of enterostatin. The trial is a placebo-controlled, dose-escalation study in healthy obese adults and is due to be completed in 2006.

The trial is designed to achieve several detailed objectives:

  • To determine the pharmacokinetics of enterostatin following oral administration;
  • To evaluate the safety and tolerability of several dose levels of enterostatin as compared to a placebo in healthy obese adults; and
  • To evaluate hunger/satiety ratings following the administration.
louis vuitton outlet louis vuitton outlet Louis Vuitton Outlet lebron 11 sport blue 14s wolf grey 3s louis vuitton outlet Louis Vuitton Outlet louis vuitton outlet cheap jordans lebron 12 foamposites for sale louis vuitton outlet louis vuitton outlet sport blue 6s jordan 3 sport blue louis vuitton outlet sport blue 3s sport blue 3s louis vuitton outlet